Association between Metformin Use and Coronary Artery Calcification in Type 2 Diabetic Patients
Objectives. Type 2 diabetes mellitus (T2DM) is associated with coronary artery calcification (CAC) which is an independent risk factor for cardiovascular events. Metformin is the first-line antidiabetic medication. We aimed to investigate the association between metformin use and CAC. Methods. We in...
Main Authors: | Yi Lu, Yidong Wang, Ting Weng, Zexin Chen, Xiujuan Sun, Jia Wei, Zhejun Cai, Meixiang Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/9484717 |
Similar Items
-
The Association Between Metformin Treatment and Outcomes in Type 2 Diabetes Mellitus Patients With Heart Failure With Preserved Ejection Fraction: A Retrospective Study
by: Jianfang Wang, et al.
Published: (2021-03-01) -
Coronary artery calcification is associated with insulin resistance index in patients with type 1 diabetes
by: T.C. Rodrigues, et al.
Published: (2010-11-01) -
Calcification and atherosclerosis of the coronary arteries
by: Elena V. Kashtanova, et al.
Published: (2021-01-01) -
AMPK: Potential Therapeutic Target for Vascular Calcification
by: Yi Lu, et al.
Published: (2021-05-01) -
Serum endostatin level as a marker for coronary artery calcification in type 2 diabetic patients
by: Hazem M. El-Ashmawy, et al.
Published: (2019-01-01)